Should oral anticoagulants still be prescribed to patients with atrial fibrillation with a single stroke risk factor but at high bleeding risk? A nationwide cohort study

Non–Vitamin K Antagonist Oral Anticoagulants in Elderly (≥85 years) Patients With Newly Diagnosed Atrial Fibrillation

(2021) Wen-Han Cheng et al.   MAYO CLINIC PROCEEDINGS

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)

(2020) Gerhard Hindricks et al.   EUROPEAN HEART JOURNAL

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2019) Craig T. January et al.   CIRCULATION

Comparing the Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin in Elderly Asian Patients With Atrial Fibrillation

(2019) Tze-Fan Chao et al.   CHEST

Lifetime Risks, Projected Numbers, and Adverse Outcomes in Asian Patients With Atrial Fibrillation

(2018) Tze-Fan Chao et al.   CHEST

Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation

(2018) Tze-Fan Chao et al.   CIRCULATION

Major bleeding and intracranial hemorrhage risk prediction in patients with atrial fibrillation: Attention to modifiable bleeding risk factors or use of a bleeding risk stratification score? A nationwide cohort study

(2018) Tze-Fan Chao et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation

(2018) Tze-Fan Chao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Incident Risk Factors and Major Bleeding in Patients with Atrial Fibrillation Treated with Oral Anticoagulants: A Comparison of Baseline, Follow-up and Delta HAS-BLED Scores with an Approach Focused on Modifiable Bleeding Risk Factors

(2018) Tze-Fan Chao et al.   THROMBOSIS AND HAEMOSTASIS

Antithrombotic Therapy for Atrial Fibrillation

(2018) Gregory Y.H. Lip et al.   CHEST

Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities

(2018) Tze-Fan Chao et al.   EUROPEAN HEART JOURNAL

Predicting Thromboembolic and Bleeding Event Risk in Patients with Non-Valvular Atrial Fibrillation: A Systematic Review

(2018) Ethan Borre et al.   THROMBOSIS AND HAEMOSTASIS

Long-term bleeding risk prediction in ‘real world’ patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores

(2017) Vanessa Roldán et al.   THROMBOSIS AND HAEMOSTASIS

Stroke prevention in atrial fibrillation: Past, present and future

(2017) Ben Freedman et al.   THROMBOSIS AND HAEMOSTASIS

Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention?

(2017) Ling Kuo et al.   Journal of the American Heart Association

Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin

(2016) Keitaro Senoo et al.   AMERICAN JOURNAL OF MEDICINE

Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial HemorrhageCLINICAL PERSPECTIVE

(2016) Tze-Fan Chao et al.   CIRCULATION

Bleeding risk assessment in atrial fibrillation: observations on the use and misuse of bleeding risk scores

(2016) G. Y. H. Lip et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Impact on Outcomes of Changing Treatment Guideline Recommendations for Stroke Prevention in Atrial Fibrillation: A Nationwide Cohort Study

(2016) Tze-Fan Chao et al.   MAYO CLINIC PROCEEDINGS

Rate-Control Treatment and Mortality in Atrial FibrillationCLINICAL PERSPECTIVE

(2015) Tze-Fan Chao et al.   CIRCULATION

Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation

(2015) Tze-Fan Chao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation?

(2015) Tze-Fan Chao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Validating the diagnosis of acute ischemic stroke in a National Health Insurance claims database

(2015) Cheng-Yang Hsieh et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey

(2014) Maura Marcucci et al.   AMERICAN JOURNAL OF MEDICINE

Using the CHA2DS2-VASc Score for Refining Stroke Risk Stratification in ‘Low-Risk’ Asian Patients With Atrial Fibrillation

(2014) Tze-Fan Chao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Continuation of statin therapy and a decreased risk of atrial fibrillation/flutter in patients with and without chronic kidney disease

(2013) Chia-Hsuin Chang et al.   ATHEROSCLEROSIS

The HAS-BLED Score Has Better Prediction Accuracy for Major Bleeding Than CHADS2 or CHA2DS2-VASc Scores in Anticoagulated Patients With Atrial Fibrillation

(2013) Vanessa Roldán et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Comparison of the CHADS2, CHA2DS2 -VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: The AMADEUS trial

(2013) Stavros Apostolakis et al.   THROMBOSIS AND HAEMOSTASIS

Bleeding and Stroke Risk in a Real-world Prospective Primary Prevention Cohort of Patients With Atrial Fibrillation

(2011) Daniela Poli et al.   CHEST

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

Validation of the national health insurance research database with ischemic stroke cases in Taiwan

(2010) Ching-Lan Cheng et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST